BIOCON:NSE
Biocon Ltd
₹352,00
arrow_upward
+0,40%(+1,40) 1D
15 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIOCON...
Open
₹354,00
High
₹356,35
Low
₹350,00
Mkt. cap
421,18 ຕື້
Avg. vol.
3,10 ລ້ານ
Volume
1,73 ລ້ານ
Dividend
0,14%
Quarterly dividend
₹0,12
Ex-dividend date
3 ກ.ລ. 2026
P/E ratio
104,21
52-wk high
₹447,15
52-wk low
₹337,70
EPS
₹3,38
Shares outstanding
600,00 ລ້ານ
No. of employees
16 ພັນ
Open
₹354,00
High
₹356,35
Low
₹350,00
Mkt. cap
421,18 ຕື້
Avg. vol.
3,10 ລ້ານ
Volume
1,73 ລ້ານ
Dividend
0,14%
Quarterly dividend
₹0,12
Ex-dividend date
3 ກ.ລ. 2026
P/E ratio
104,21
52-wk high
₹447,15
52-wk low
₹337,70
EPS
₹3,38
Shares outstanding
600,00 ລ້ານ
No. of employees
16 ພັນ
News stories
From web sources and news partners
TipRanks
·
1 ມື້ກ່ອນ
Biocon Secures Global Deal with Genentech to Launch Pebrilzo Biosimilar
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16,4 ພັນ
Founded29 ພ.ຈ. 1978
Headquartersບັງຄາລໍ, ກະຣະນາຕະກະ, ອິນເດຍ
SectorBiotechnology
Websitebiocon.com